Anteris Technologies Global Cor (AVR) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Anteris Technologies Global Cor

NasdaqGM•Healthcare•Medical Instruments & Supplies

$8.30-0.23(-0.03%)After hours

Market Cap

$812.79M

P/S

362.5x

P/B

3.2x

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

How this company scores

WeakMetricSide Score: 44/100

Grade capped at D — Interest coverage below 1× (-202.7x) — earnings cannot cover interest. Strongest: Balance Sheet & Red Flags (17/25); weakest: Cash & Earnings Quality (6/25).

Profitability11/25

Growth10/25

Balance Sheet & Red Flags17/25

Cash & Earnings Quality6/25

Strengths

Long cash runwayLow leverageImproving leverageConsistent growth

Grade capped at D

Interest coverage below 1× (-202.7x) — earnings cannot cover interest.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/S · 362.5x5y range 104.9x – 362.5x

P/B · 3.2x5y range 1.5x – 42.5x

Currently near its 5-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 6 of the last 6 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $812.79M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $2.24M
Q. Revenue: $1.01M
TTM EBITDA: $-104.50M
TTM Op. Income: $-106.23M
Q. Op. Income: $-31.00M
TTM Net Income: $-103.56M
Q. Net Income: $-29.09M
EPS: $-0.3
Shares Out.: $97.34M

$2.24M in TTM revenue grew from zero YoY, reaching $1.01M last quarter. TTM EBITDA of $-104.50M and TTM operating income of $-106.23M show growth is flowing through to the bottom line. However, net income is negative at $103.56M — growth is not yet reaching the bottom line. Over the past year, TTM revenue is up 0% — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 76.9%
EBITDA Margin: -3025.6%
Op. Margin: -3072.1%
Net Margin: -2883.4%

Op. margin of -3072.1% is up 307.2% YoY — cost efficiency is improving. Net margin at -2883.4% and gross margin of 76.9% show how much of each revenue dollar survives to profit. Across the last 6 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 362.5x
P/B Ratio: 3.2x

P/S of 362.5x and P/B of 3.2x. P/S is high, meaning growth expectations are priced in.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $272.51M
Cash: $249.90M
Long-Term Debt: $47,000
Book Value: $251.39M
D/E Ratio: 0.0
Debt/EBITDA: N/A

With $272.51M in assets and $47,000 in long-term debt, D/E is 0.0and book value is $251.39M — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is down 73% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-20.80M
TTM Free Cash Flow: $-88.21M
FCF Margin: -3934.4%
FCF / Net Income: 0.9

TTM FCF of $-88.21M on $-20.80M in operating cash flow. The FCF / Net Income ratio of 0.9x means free cash flow covers net income — earnings are backed by cash. Across the last 6 quarters, free cash flow has fallen for 3 consecutive quarters — a weakening trend.